VWF, von Willebrand factor, 7450

N. diseases: 498; N. variants: 158
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE Acquired thrombotic thrombocytopenic purpura (TTP) is a potentially fatal disease in which ultralarge von Willebrand factor (UL-VWF) multimers accumulate as a result of autoantibody inhibition of the VWF protease, ADAMTS13. 27040023 2016
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE Recent studies demonstrate that assay of ADAMTS13, a circulating zinc metalloprotease that cleaves von Willebrand factor (VWF) at the Y1605-M1606 bond, is an important tool in the diagnosis of thrombotic thrombocytopenic purpura (TTP). 15045144 2004
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE Severe deficiency of ADAMTS13, a von Willebrand factor (VWF)-cleaving metalloprotease, causes thrombotic thrombocytopenic purpura. 17426255 2007
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE In TTP thrombi formation occurs subsequently to the release of multimers of von Willebrand Factor (vWF) and in HUS (both typical and atypical) to endothelial cell damage (via toxins or complement dysregulation). 19640589 2009
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE As the anchored VWF chains grow, they provide a greater surface area to bind circulating platelets (PLTs), generating unique thrombi that characterize TTP. 30208220 2018
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE ADAMTS13 and von Willebrand factor (VWF) are closely related to the onset of TTP. 26759371 2017
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE In some variants of type 2A vWF, the cleavage site in the vWF subunit is more susceptible to proteolytic degradation than in normal vWF, whereas in patients with TTP or HUS the protease activity may be suppressed. vWF-degrading protease plays an important role in pathogenesis of congenital or acquired disorders of hemostasis and thrombosis. 8767102 1996
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE Failure to degrade "unusually large" (UL) von Willebrand factor (VWF) multimers as they are secreted from endothelial cells probably causes most cases of familial TTP, acquired idiopathic TTP, thienopyridine-related TTP, and pregnancy-associated TTP. 14727254 2004
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE The deficiency of ADAMTS13 leaves unchecked the hyperadhesive vWF unfolded under high shear stress in the microvessels, resulting in the formation of platelet thrombi, which in turn causes TTP. 16388413 2005
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE Deficiency of von Willebrand factor (VWF) cleaving protease ADAMTS13 has been demonstrated to be the proximate cause of a subset of thrombotic microangiopathic haemolytic anaemias (MAHA) typical for thrombotic thrombocytopenic purpura (TTP). 15009067 2004
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE This observation led to the recognition that UL vWF multimers precipitate the thrombotic occlusion of arterioles, a feature that characterizes TTP. 12656756 2003
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE Thrombotic thrombocytopenic purpura (TTP) is caused by the persistence of the highly reactive high-molecular-weight multimers of von Willebrand factor (VWF) due to deficiency of the specific VWF-cleaving protease (VWF-CP) ADAMTS13, resulting in microangiopathic disease. 12393505 2003
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE von Willebrand factor and its cleaving protease ADAMTS13 balance in coronary artery vessels: Lessons learned from thrombotic thrombocytopenic purpura. A narrative review. 28521259 2017
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE In the past 10 years the molecular bases of aHUS and TTP have been discovered that mostly lead to uncontrolled activation of the complement system in aHUS and to abnormal von Willebrand factor processing in TTP. 20807612 2010
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE Thrombotic thrombocytopenic purpura (TTP) is an acute life-threatening microangiopathy with a tendency of relapse characterized by consumptive thrombocytopenia, microangiopathic hemolytic anemia, and spontaneous von Willebrand factor-induced platelet clumping leading to microthrombi. 28337761 2017
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE Together, these findings shed new light on the potential roles played by ADAMTS13 and VWF in TTP, endotoxemia, and normal hemostasis. 18083848 2008
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE Severe deficiency of the von Willebrand Factor (VWF)-cleaving proteinase, ADAMTS13, is associated with the development of thrombotic thrombocytopenic purpura (TTP). 14512317 2004
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. 25587650 2015
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE In fact, while the presence in plasma of unusually large VWF multimers due to a congenital or acquired deficiency of a VWF-cleaving metalloprotease has been implicated in the pathogenesis of thrombotic thrombocytopenic purpura (TTP), high plasma levels of VWF have been associated with a slightly increased risk of arterial thrombosis. 16568319 2006
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE Deficient von Willebrand factor (VWF) degradation has been associated with thrombotic thrombocytopenic purpura (TTP). 12393399 2002
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE Recent studies on the relationship between UL-vWFMs and vWF-CPase, together with its autoantibody (inhibitor) have brought about a clear discrimination between thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. 11843286 2002
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease LHGDN Failure to degrade "unusually large" (UL) von Willebrand factor (VWF) multimers as they are secreted from endothelial cells probably causes most cases of familial TTP, acquired idiopathic TTP, thienopyridine-related TTP, and pregnancy-associated TTP. 14727254 2004
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE The metalloprotease ADAMTS-13 cleaves von Willebrand factor (VWF), and is absent or severely reduced in the plasma of patients with thrombotic thrombocytopenia purpura (TTP). 14652658 2003
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE Thrombotic thrombocytopenic purpura (TTP) is a rare but serious disease caused by autoantibody-mediated deficiency in von Willebrand factor (VWF) cleaving protease, ADAMTS-13. 27246502 2017
Purpura, Thrombotic Thrombocytopenic
0.100 Biomarker disease BEFREE Deficiency of von Willebrand factor (VWF) cleaving protease ADAMTS13 is associated with the development of thrombotic thrombocytopenic purpura (TTP). 12576319 2003